We found an association between elevated acute-phase plasma concentrations of the novel blood-based biomarker BD-tau and unfavorable functional outcome after ischemic stroke that was independent of both age and stroke severity (a proxy for infarct size), the 2 strongest known predictors of poststroke outcome,11 in 2 independent cohorts. This evidence concerns the gene MAPT and ischemic stroke.